(Q39979513)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Mitsuyoshi Yoshimoto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Kohshin Washiyama

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Naoto Shikano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Hirofumi Mori

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Ryohei Amano

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Keiichi Kawai

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

English

0 references

publication date

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498129%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498129%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

709-715

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18498129%20AND%20SRC:MED&resulttype=core&format=json

Role of integrins in angiogenesis

7 January 2020

cites work

1 reference

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting

21 January 2018

1 reference

In vitro and in vivo effects of a cyclic peptide with affinity for the alpha(nu)beta3 integrin in human melanoma cells

21 January 2018

1 reference

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

21 January 2018

1 reference

Integrin activation controls metastasis in human breast cancer

21 January 2018

1 reference

Human melanoma cells derived from lymphatic metastases use integrin alpha v beta 3 to adhere to lymph node vitronectin

21 January 2018

1 reference

Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis?

21 January 2018

1 reference

(64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression

21 January 2018

1 reference

Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting

21 January 2018

1 reference

Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation

21 January 2018

1 reference

213Bi-[DOTA0, Tyr3]octreotide peptide receptor radionuclide therapy of pancreatic tumors in a preclinical animal model

21 January 2018

1 reference

MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide

21 January 2018

1 reference

Bone resorption by osteoclasts

21 January 2018

1 reference

Fractionated locoregional low-dose radioimmunotherapy improves survival in a mouse model of diffuse-type gastric cancer using a 213Bi-conjugated monoclonal antibody

21 January 2018

1 reference

Rationales, evidence, and design considerations for fractionated radioimmunotherapy

21 January 2018

1 reference

Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of (86)Y-DOTATOC and (111)In-DTPA-octreotide

21 January 2018

1 reference

86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion

21 January 2018

1 reference

Toxicity and dosimetry of (177)Lu-DOTA-Y3-octreotate in a rat model.

21 January 2018

1 reference

Is the Renal Dosimetry for [90Y-DOTA0, Tyr3]Octreotide Accurate Enough to Predict Thresholds for Individual Patients?

21 January 2018

1 reference

Expression and Function of β1 and αvβ3 Integrins in Ovarian Cancer

21 January 2018

1 reference